Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.

about

The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases.

P2860

Q47604110-0DB5A484-5533-40E8-A80B-4B58C2BAC4B1

P2860

Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.

Item

http://www.wikidata.org/entity/Q39073840

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@en

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@nl

type

Item

label

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@en

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@nl

prefLabel

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@en

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@nl

P1476

Prevalence of EGFR Tyrosine Ki ...... t Study and Systematic Review.

@en

P2093

Christos Perisanidis

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Molecular pathology of lung cancer: key to personalized medicine.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Comprehensive genomic characterization of head and neck squamous cell carcinomas

P304

23-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11020

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28064216

http://www.w3.org/2001/XMLSchema#string

P932

5354143

http://www.w3.org/2001/XMLSchema#string

Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.

about

P2860

P2860

Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932